LianBio (LIAN)
NASDAQ: LIAN
· Real-Time Price · USD
0.32
0.00 (0.31%)
At close: Jan 16, 2025, 10:00 PM
LianBio Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 1.24M | 1.23M | 1.14M | 813.25K | 496.77K | 199.01K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -1.24M | -1.23M | -1.14M | -813.25K | -496.77K | -199.01K | n/a | n/a | n/a | n/a | n/a |
Operating Income | -106.56M | -104.81M | -122.91M | -125.35M | -118.14M | -107.14M | -163.49M | -195.57M | -182.74M | -288.24M | -188.75M |
Interest Income | 7.87M | 6.57M | 4.36M | 2.24M | 2.31M | 937.14K | 490.14K | 243.14K | 171K | 139K | 33K |
Pretax Income | -87.11M | -85.55M | -106.51M | -110.62M | -114.23M | -105.84M | -162.91M | -195.78M | -186.29M | -293.02M | -193.56M |
Net Income | -87.98M | -85.84M | -106.61M | -110.29M | -113.21M | -104.42M | -162.46M | -196.3M | -187.84M | -294.97M | -194.54M |
Selling & General & Admin | 66.68M | 65.69M | 64.65M | 65.6M | 61.31M | 53.91M | 45.82M | 36.88M | 28.99M | 22.23M | 15.77M |
Research & Development | 39.88M | 39.12M | 58.26M | 59.76M | 56.83M | 53.23M | 117.67M | 158.69M | 153.75M | 266.01M | 172.98M |
Other Expenses | 9.5M | 10.61M | 9.95M | 10.41M | 1.61M | 358K | 87K | -454K | -147K | -51K | 17K |
Operating Expenses | 106.56M | 104.81M | 122.91M | 125.35M | 118.14M | 107.14M | 163.49M | 195.57M | 182.74M | 288.24M | 188.75M |
Interest Expense | n/a | 1.41M | 1.96M | 1.96M | 2.2M | 828K | 275K | 275K | 32K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 106.56M | 104.81M | 122.91M | 125.35M | 118.14M | 107.14M | 163.49M | 195.57M | 182.74M | 288.24M | 188.75M |
Income Tax Expense | 874K | 294K | 99K | -333K | -1.02M | -1.42M | -451K | 518K | 1.55M | 3.25M | 2.27M |
Shares Outstanding (Basic) | 107.17M | 107.16M | 107.16M | 108.13M | 108.35M | 107.92M | 107.28M | 75.48M | 105.26M | 105.26M | 105.26M |
Shares Outstanding (Diluted) | 107.17M | 107.16M | 107.16M | 108.13M | 108.35M | 107.92M | 107.28M | 75.48M | 105.26M | 105.26M | 105.26M |
EPS (Basic) | -0.81 | -0.79 | -0.98 | -1.02 | -1.13 | -1.05 | -1.61 | -1.93 | -1.77 | -13.36 | -12.41 |
EPS (Diluted) | -0.81 | -0.79 | -0.98 | -1.02 | -1.13 | -1.05 | -1.61 | -1.93 | -1.77 | -13.36 | -12.41 |
EBITDA | -105.26M | -103.55M | -121.85M | -124.35M | -117.21M | -106.34M | -162.76M | -195.04M | -182.41M | -288.03M | -188.61M |
EBIT | -106.56M | -104.81M | -122.91M | -125.35M | -118.14M | -107.14M | -163.49M | -195.57M | -182.74M | -288.24M | -188.75M |
Depreciation & Amortization | 1.3M | 1.25M | 1.06M | 1.01M | 936K | 797K | 730K | 525K | 324K | 211K | 140K |